Latest Breaking News On - Bharat biotechhyderabad - Page 1 : comparemela.com

Regulatory approvals for COVAXIN is in process in more than 60 countries: Bharat Biotech

Regulatory approvals for COVAXIN is in process in more than 60 countries: Bharat Biotech Hyderabad, May 25 (UNI) Regulatory approvals for indigenously developed Covid-19 vaccine ‘Covaxin’ are in process in more than 60 countries including USA, Brazil and Hungary, according to Hyderabad-based global vaccine maker Bharat Biotech here on Tuesday. Emergency use authorisations (EUA) have been obtained from 13 countries with more to follow. Bharat Biotech has submitted an application to the World Health Organisation (WHO ) for EUL (Emergency Use Listing) for indigenously developed Covid-19 vaccine ‘Covaxin ‘ and regulatory approvals are expected by Jul-Sept 2021. Most countries recommend vaccinations against COVID-19. Unvaccinated travelers can travel with negative RT-PCR tests prior to travel, in the absence of any other country specific travel restrictions.

PhilippinesUnited statesIranPuneMaharashtraIndiaBrazilBangaloreKarnatakaDelhiGuatemalaNicaraguaMexicoMumbaiHyderabadAndhra pradesh

Regulatory approvals for COVAXIN is in process in more than 60 countries: Bharat Biotech

Regulatory approvals for COVAXIN is in process in more than 60 countries: Bharat Biotech
uniindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from uniindia.com Daily Mail and Mail on Sunday newspapers.

PhilippinesUnited statesIranPuneMaharashtraIndiaBrazilBangaloreKarnatakaDelhiGuatemalaNicaraguaMexicoMumbaiHyderabadAndhra pradesh

BioAsia 2021 Announces the Genome Valley Excellence Award to Bharat Biotech

BioAsia 2021 Announces the Genome Valley Excellence Award to Bharat Biotech Hyderabad, Feb 16 (UNI) BioAsia, Asia s largest annual global Biotechnology and Life Sciences forum organized by the Government of Telangana, has announced that the prestigious Genome Valley Excellence Award for the year 2021 will be bestowed upon Bharat Biotech International Limited for its breakthrough, pioneering research, development and commercialization of vaccines. The vaccines include COVAXIN™ (COVID-19 Vaccine), Rabies vaccine, Rotavirus vaccine, Japanese Encephalitis vaccine, Polio vaccine and Typhoid Conjugate vaccines, among others that have helped save billions of lives globally. Dr Krishna M Ella, Chairman & Managing Director, and Ms Suchitra Ella, Joint Managing Director, Bharat Biotech International will receive the award on February 22, 2021, during the inaugural event of BioAsia 2021, a release here said on Tuesday.

JapanUnited statesIndiaTelanganaAndhra pradeshBelgiumJapaneseRobert naismithMakarand jawadekarKrishnam ellaBharat biotechhyderabadSuchitra ellaJanssen pharmaceuticaPfizerInternational advisory board of bioasiaJujama inc